<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8692924" created="20/11/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8692924</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="BCL-6" sem="Protein_molecule">BCL-6</term>, a <term id="T2" lex="POZ/zinc-finger_protein" sem="Protein_family_or_group">POZ/zinc-finger protein</term>, is a <term id="T3" lex="sequence-specific_transcriptional_repressor" sem="Protein_family_or_group">sequence-specific transcriptional repressor</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Approximately 40% of <term id="T4" lex="diffuse_large_cell_lymphoma" sem="Other">diffuse large cell lymphoma</term> are associated with <term id="T5" lex="chromosomal_translocation" sem="Other">chromosomal translocations</term> that deregulate the expression of the <term id="T6" lex="BCL6_gene" sem="DNA_domain_or_region">BCL6 gene</term> by juxtaposing <term id="T7" lex="heterologous_promoter" sem="DNA_domain_or_region">heterologous promoters</term> to the <term id="T8" lex="BCL-6_coding_domain" sem="DNA_domain_or_region"><term id="T9" lex="BCL-6" sem="Protein_molecule">BCL-6</term> coding domain</term>.</sentence>
<event KT="Fact" id="E1">
<type class="Correlation"/>
<theme idref="T4"/>
<theme idref="T5"/>
<clue>Approximately 40% of diffuse large cell lymphoma are <clueType>associated</clueType> <linkTheme>with</linkTheme> chromosomal translocations that deregulate the expression of the BCL6 gene by juxtaposing heterologous promoters to the BCL-6 coding domain.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T6"/>
<clue>Approximately 40% of diffuse large cell lymphoma are associated with chromosomal translocations that deregulate the <clueType>expression</clueType> <linkTheme>of</linkTheme> the BCL6 gene by juxtaposing heterologous promoters to the BCL-6 coding domain.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E3">
<type class="Regulation"/>
<theme idref="E2"/>
<cause idref="T5"/>
<clue>Approximately 40% of diffuse large cell lymphoma are associated with chromosomal translocations that <clueType><cluePolarity>deregulate</cluePolarity></clueType> the expression of the BCL6 gene by juxtaposing heterologous promoters to the BCL-6 coding domain.</clue>
</event>
<sentence id="S3">The <term id="T10" lex="BCL6_gene" sem="DNA_domain_or_region">BCL6 gene</term> encodes a <term id="T11" lex="95-kDa_protein" sem="Protein_molecule">95-kDa protein</term> containing six <term id="T12" lex="C-terminal_zinc-finger_motif" sem="Protein_substructure">C-terminal zinc-finger motifs</term> and an <term id="T13" lex="N-terminal_POZ_domain" sem="Protein_domain_or_region">N-terminal POZ domain</term>, suggesting that it may function as a <term id="T14" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term>.</sentence>
<sentence id="S4">By using a <term id="T15" lex="DNA_sequence" sem="DNA_domain_or_region">DNA sequence</term> selected for its ability to bind <term id="T16" lex="recombinant_BCL-6" sem="Protein_molecule">recombinant <term id="T17" lex="BCL-6" sem="Protein_molecule">BCL-6</term></term> in vitro, we show here that <term id="T18" lex="BCL-6" sem="Protein_molecule">BCL-6</term> is present in <term id="T19" lex="DNA-binding_complex" sem="Protein_complex">DNA-binding complexes</term> in <term id="T20" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> from various <term id="T21" lex="B-cell_line" sem="Cell_cultured">B-cell lines</term>.</sentence>
<sentence id="S5">In transient transfectin experiments, <term id="T22" lex="BCL6" sem="Protein_molecule">BCL6</term> can repress <term id="A4" sem="Other">transcription</term> from <term id="T23" lex="promoter" sem="DNA_family_or_group">promoters</term> linked to its <term id="T24" lex="DNA_target_sequence" sem="DNA_domain_or_region">DNA target sequence</term> and this activity is dependent upon specific <term id="T25" lex="DNA-binding" sem="Other">DNA-binding</term> and the presence of an intact <term id="T26" lex="N-terminal_half" sem="Protein_domain_or_region">N-terminal half</term> of the protein.</sentence>
<event KT="Other" id="E4">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="T23"/>
<clue>In transient transfectin experiments, BCL6 can repress transcription <linkCause>from</linkCause> promoters linked to its DNA target sequence and this activity is dependent upon specific DNA-binding and the presence of an intact N-terminal half of the protein.</clue>
<comment>NO CLUETYPE</comment></event>
<event CL="L2" KT="Analysis" id="E5">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<cause idref="T22"/>
<clue>In transient transfectin experiments, BCL6 <clueKT><clueCL>can</clueCL></clueKT> <clueType>repress</clueType> transcription from promoters linked to its DNA target sequence and this activity is dependent upon specific DNA-binding and the presence of an intact N-terminal half of the protein.</clue>
</event>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T25"/>
<clue>In transient transfectin experiments, BCL6 can repress transcription from promoters linked to its DNA target sequence and <corefTheme>this activity</corefTheme> is <clueType>dependent</clueType> <linkCause>upon</linkCause> specific DNA-binding and the presence of an intact N-terminal half of the protein.</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T26"/>
<clue>In transient transfectin experiments, BCL6 can repress transcription from promoters linked to its DNA target sequence and <corefTheme>this activity</corefTheme> is <clueType>dependent</clueType> <linkCause>upon</linkCause> specific DNA-binding and the presence of an intact N-terminal half of the protein.</clue>
</event>
<sentence id="S6">We demonstrate that this part of the <term id="T27" lex="BCL6_molecule" sem="Protein_molecule"><term id="T28" lex="BCL6" sem="Protein_molecule">BCL6</term> molecule</term> contains an <term id="T29" lex="autonomous_transrepressor_domain" sem="Protein_domain_or_region">autonomous transrepressor domain</term> and that two <term id="T30" lex="noncontiguous_regions" sem="Protein_domain_or_region">noncontiguous regions</term>, including the <term id="T31" lex="POZ_motif" sem="Protein_substructure">POZ motif</term>, mediate maximum <term id="T32" lex="transrepressive_activity" sem="Other">transrepressive activity</term>.</sentence>
<event KT="Analysis" id="E8">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T30"/>
<clue>We <clueKT>demonstrate</clueKT> that this part of the BCL6 molecule contains an autonomous transrepressor domain and that two noncontiguous regions, including the POZ motif, <clueType>mediate</clueType> maximum transrepressive activity.</clue>
</event>
<sentence id="S7">These results indicate that the <term id="T33" lex="BCL-6_protein" sem="Protein_molecule"><term id="T34" lex="BCL-6" sem="Protein_molecule">BCL-6</term> protein</term> can function as a <term id="T35" lex="sequence-specific_transcriptional_repressor" sem="Protein_family_or_group">sequence-specific transcriptional repressor</term> and have implications for the role of <term id="T36" lex="BCL6" sem="Protein_molecule">BCL6</term> in <term id="T37" lex="normal_lymphoid_development" sem="Other">normal <term id="A3" sem="Cell_natural">lymphoid</term> development</term> and <term id="T38" lex="lymphomagenesis" sem="Other">lymphomagenesis</term>.</sentence>
<event KT="Other" id="E9">
<type class="Cellular_physiological_process"/>
<theme idref="A3"/>
<clue>These results indicate that the BCL-6 protein can function as a sequence-specific transcriptional repressor and have implications for the role of BCL6 in normal lymphoid <clueType>development</clueType> and lymphomagenesis.</clue>
</event>
<event CL="L2" KT="Analysis" id="E10" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T36"/>
<clue>These results indicate that the BCL-6 protein can function as a sequence-specific transcriptional repressor and have <clueKT><clueCL>implications</clueCL></clueKT> for the <clueType>role</clueType> <linkCause>of</linkCause> BCL6 <linkTheme>in</linkTheme> normal lymphoid development and lymphomagenesis.</clue>
</event>
<event CL="L2" KT="Analysis" id="E11" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T38"/>
<clue>These results indicate that the BCL-6 protein can function as a sequence-specific transcriptional repressor and have <clueKT><clueCL>implications</clueCL></clueKT> for the <clueType>role</clueType> <linkCause>of</linkCause> BCL6 <linkTheme>in</linkTheme> normal lymphoid development and lymphomagenesis.</clue>
</event>
<event CL="L2" KT="Analysis" id="E12">
<type class="Negative_regulation"/>
<cause idref="T33"/>
<clue>These results <clueKT>indicate</clueKT> that the BCL-6 protein <clueCL>can</clueCL> <clueType>function as</clueType> a sequence-specific <clueType>transcriptional repressor</clueType> and have implications for the role of BCL6 in normal lymphoid development and lymphomagenesis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
